By GlaxoSmithKline | February 6, 2019GSK, Merck Strike $4.2 Billion Partnership Deal to Develop Cancer Immunotherapy
By GlaxoSmithKline | February 8, 2018Viiv Healthcare Launches Eighth Phase III Study in Two-Drug Regimen Program for HIV-1 Treatment
By GlaxoSmithKline | January 26, 2018GSK’s Shingrix Receives Positive Opinion from CHMP for Prevention of Shingles
By GlaxoSmithKline | May 5, 2017GSK, Innoviva Announce Positive Phase 3 Results for Novel Asthma Treatment